Editorial: Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe?

Lise Lotte Gluud; Nina Kimer; Søren Møller

doi:10.1111/apt.17099

Editorial: Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe?

Lise Lotte Gluud^*, Nina Kimer, Søren Møller

^*Corresponding author for this work

Research output: Contribution to journal › Editorial › Research › peer-review

1 Citation (Scopus)

Original language	English
Journal	Alimentary Pharmacology and Therapeutics
Volume	56
Issue number	5
Pages (from-to)	909-910
Number of pages	2
ISSN	0269-2813
DOIs	https://doi.org/10.1111/apt.17099
Publication status	Published - 2022

Access to Document

10.1111/apt.17099

Cite this

@article{18b44c3b549442ea84e2821b2d1cdf44,

title = "Editorial: Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe?",

author = "Gluud, {Lise Lotte} and Nina Kimer and S{\o}ren M{\o}ller",

note = "Funding Information: Dr Gluud research funding from Novo Nordisk, Alexion, Gilead, Vingmed and honoraria as consultant/speaker/expert testimony from Novo Nordisk, Pfizer, Sobi International, and Norgine. Dr Kimer speaker, Norgine. Dr M{\o}ller, none declared. Declaration of personal interests: ",

year = "2022",

doi = "10.1111/apt.17099",

language = "English",

volume = "56",

pages = "909--910",

journal = "Alimentary Pharmacology and Therapeutics, Supplement",

issn = "0953-0673",

publisher = "Wiley-Blackwell",

number = "5",

}

TY - JOUR

T1 - Editorial

T2 - Percutaneous placement of a permanent tunnelled catheter for patients with non-malignant ascites—Is it safe?

AU - Gluud, Lise Lotte

AU - Kimer, Nina

AU - Møller, Søren

N1 - Funding Information: Dr Gluud research funding from Novo Nordisk, Alexion, Gilead, Vingmed and honoraria as consultant/speaker/expert testimony from Novo Nordisk, Pfizer, Sobi International, and Norgine. Dr Kimer speaker, Norgine. Dr Møller, none declared. Declaration of personal interests:

PY - 2022

Y1 - 2022

U2 - 10.1111/apt.17099

DO - 10.1111/apt.17099

M3 - Editorial

C2 - 35934857

AN - SCOPUS:85135523192

VL - 56

SP - 909

EP - 910

JO - Alimentary Pharmacology and Therapeutics, Supplement

JF - Alimentary Pharmacology and Therapeutics, Supplement

SN - 0953-0673

IS - 5

ER -